Faron and Turku PET Centre team up to develop Clevegen
30 June 2015 | By Victoria White
Faron Pharmaceuticals is to collaborate with the Turku PET Centre on the development of its novel cancer immunotherapy Clevegen...
List view / Grid view
News
Bioiberica to trial new compound that may prevent memory loss in patients with mild Alzheimer’s
29 June 2015 | By Victoria White
A new compound of animal origin, developed by Bioiberica, has achieved positive results in slowing down the progression of Alzheimer's in animal models...
Researchers find new antibodies that protect against Marburg virus
29 June 2015 | By Victoria White
A study led by scientists at The Scripps Research Institute has identified new immune molecules that protect against Marburg virus, a relative of Ebola...
Immunocore and Lilly announce immunotherapy-based clinical trial collaboration in melanoma
29 June 2015 | By Victoria White
Immunocore and Lilly have entered into a collaboration to explore the utility of IMCgp100 in combination with galunisertib and merestinib in melanoma...
Preclinical data on Neuralstem’s genetically modified HK532-IGF-1 stem cells in Alzheimer’s disease presented at ISSCR
26 June 2015 | By Victoria White
Neuralstem has presented preclinical data on genetically modified HK532-IGF-1 stem cells in Alzheimer's disease at the ISSCR Annual Meeting...
A close-up view of the Ebola virus life cycle
26 June 2015 | By Victoria White
A new study by scientists from the Scripps Research Institute reveals a key part of the Ebola virus life cycle at a higher resolution than ever before...
Siemens and BioNTech cooperate on production of personalised cancer vaccines
26 June 2015 | By Victoria White
Siemens and BioNTech will work together on the construction of a fully automated and digitalised production site for BioNTech's personalised cancer vaccines...
Invenra and Oxford BioTherapeutics enter collaboration to discover novel therapeutic antibodies targeting cancer
26 June 2015 | By Victoria White
Invenra and Oxford BioTherapeutics are to collaborate to identify and characterise a panel of fully human therapeutic mAbs against a novel cancer target...
Researchers uncover epigenetic switches that turn stem cells into endothelial cells
26 June 2015 | By Victoria White
UIC Researchers have identified a molecular mechanism that directs embryonic stem cells to mature into endothelial cells...
UCL scientists design compound that shrinks pancreatic cancer tumours and prevents regrowth
25 June 2015 | By Victoria White
Scientists from University College London have designed a chemical compound that has reduced the growth of pancreatic cancer tumours by 80% in treated mice...
Researchers grow types of neurons affected by Parkinson’s disease
25 June 2015 | By Victoria White
Researchers have grown the types of neurons affected by Parkinson's disease, starting from neuronal stem cells in a three-dimensional cell culture system...
Bristol-Myers Squibb expands R&D presence in the US
25 June 2015 | By Victoria White
Bristol-Myers Squibb Company has announced important next steps in the evolution of the Company’s R&D organisation...
ViraTherapeutics raises €3.6 million to advance its lead product VSV-GP
24 June 2015 | By Victoria White
ViraTherapeutics has announced the first closing of a Series A financing round, raising €3.6 million that it will use to advance its lead product VSV-GP...
Sandoz to speak on their first Biosimilar approved by the FDA at Biosimilars & Biobetters USA in Iselin
24 June 2015 | By Biosimilars and Biobetters
SMi Group reports (2015.06.23 – Iselin, New Jersey, USA): John Pakulski, Head US Biopharmaceutical Regulatory Affairs, Sandoz, will be presenting on Day of the SMi’s Biosimilars & Biobetters USA conference in Iselin (16th-17th November 2015). Registration to the event is now open...
Novogen’s Anisina on track to enter the clinic in 2016
24 June 2015 | By Victoria White
Novogen has announced that its candidate cytotoxic chemotherapy drug, Anisina, has proved an effective anti-cancer agent in animals...